BAYN.SW stock down 46.54% to CHF36.35 on SIX 13 Jan 2026 market closed: assess valuation and catalysts
The BAYN.SW stock fell 46.54% to CHF36.35 on SIX at market close on 13 Jan 2026. Today’s move shows a large intraday gap from the previous close of CHF67.99 on very light volume (550 shares). The size of the drop and the low volume suggest a sharp revaluation or technical event rather than broad selling. Investors should check SIX notices and company filings and compare fundamentals to the new price.
BAYN.SW stock: today’s move and market facts
Bayer AG (BAYN.SW) closed at CHF36.35, down CHF31.64 or 46.54% from the prior close of CHF67.99. Trading volume was 550.00 shares, with the day low and high both at CHF36.35, indicating limited intraday trades.
Market cap is CHF35711112400.00. The one-day gap with thin volume suggests a corporate action, data feed adjustment, or concentrated orders. Confirming SIX notices is essential before trading.
Valuation and key financial metrics for BAYN.SW stock
On the current price, headline ratios read EPS CHF4.74 and PE 7.67 from the quote feed. Book value per share is CHF30.99, and price-to-book sits near 1.18, showing the share price is close to reported equity per share.
Short and medium moving averages sit much higher: 50-day average CHF110.61 and 200-day average CHF171.70. Year high and low are CHF200.00 and CHF36.35, respectively, reflecting large prior volatility.
Sector and technical context for BAYN.SW stock
Bayer trades on SIX in the Switzerland market and sits in the Healthcare sector, industry Drug Manufacturers – General. Sector strength matters because pharma and crop science news often drive re-ratings.
Price sits well below averages and near the reported year low. Technical indicators show extreme downside vs. the 50-day and 200-day averages, which increases volatility and raises short-term downside risk.
Meyka AI grade and BAYN.SW stock forecast
Meyka AI rates BAYN.SW with a score out of 100: 64.67 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects CHF67.99 as the one-year baseline. Compared with the current price of CHF36.35, that implies an upside of 87.06% to the forecast. Forecasts are model-based projections and not guarantees.
Risks and catalysts affecting BAYN.SW stock
Key risks include litigation and regulatory outcomes, trial readouts, agricultural cycle swings in Crop Science, and pharma pipeline setbacks. These can trigger large price moves for Bayer and impact earnings.
Near-term catalysts to watch are corporate filings, SIX notices, and the scheduled earnings date on 2025-03-05. Any clear update may restore liquidity or further pressure the price.
Top losers trading approach for BAYN.SW stock
As a top loser on SIX, BAYN.SW stock warrants a wait-for-confirmation approach. Watch for a meaningful rise in volume and an official explanation from Bayer before acting.
Short-term traders should use strict risk controls. Long-term investors should compare the new price to fundamentals, expected cash flow, and the Meyka AI forecast before increasing exposure.
Final Thoughts
BAYN.SW stock closed sharply lower at CHF36.35 on 13 Jan 2026, marking a 46.54% one-day decline on SIX with only 550.00 shares traded. The extreme gap and thin volume suggest a data or corporate-event driver; investors should confirm official notices. Valuation metrics show EPS CHF4.74, PE 7.67, and book value CHF30.99, keeping the company near tangible equity per share. Meyka AI’s forecast model projects CHF67.99, implying an upside of 87.06% from today’s price, but this is a model projection and not a guarantee. Given the current volatility, our grade (64.67, B, HOLD) reflects mixed signals: solid cash flow metrics versus heightened event risk. Immediate action should be limited to monitoring official disclosures, volume confirmation, and the March earnings window. For disciplined investors, a staged entry with stop-loss limits and attention to legal or regulatory updates offers a measured path back into the name.
FAQs
What caused the BAYN.SW stock drop on 13 Jan 2026?
The quote shows a 46.54% fall to CHF36.35 on thin volume (550). The drop likely links to a technical or corporate event. Verify SIX notices and Bayer filings for the precise cause before trading.
How does the Meyka AI forecast affect BAYN.SW stock outlook?
Meyka AI’s forecast model projects CHF67.99, implying about 87.06% upside from CHF36.35. This projection guides valuation checks but is model-based and not a guarantee.
Should investors buy BAYN.SW stock after the large one-day drop?
With extreme volatility and low volume, wait for confirmatory news and higher liquidity. Use staged buys and tight risk management if fundamentals and the Meyka AI forecast align with your strategy.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
